Literature DB >> 27859490

Genetically modified rodent models of SCA17.

Yiting Cui1,2, Su Yang2, Xiao-Jiang Li2, Shihua Li2.   

Abstract

Spinocerebellar ataxia type 17 (SCA17) is a type of autosomal dominant cerebellar ataxia (ADCA) characterized by variable manifestations, including cerebellar ataxia, dementia, and psychiatric symptoms. Since the identification of a CAG repeat expansion in the TATA-box binding protein (TBP) gene in a patient with ataxia in 1999 and then verification of this expansion in patients with SCA17 in 2001, several SCA17 rodent models, including both knock-in and transgenic models in mice and rats, have been established to explore the phenotypic features and pathogenesis of SCA17. These animal models revealed different pathological changes and phenotypes that are associated with the expression of mutant TBP protein and the CAG repeat lengths. It is important to understand how mutant TBP can cause differential pathological events in SCA17 animal models. In this review, we summarize and compare these animal models for the nature of transgenes and their expression as well as phenotypical features. We also discuss potential directions for future studies.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  HDL4; Huntington disease-like 4; SCA17; spinocerebellar ataxia type 17

Mesh:

Substances:

Year:  2016        PMID: 27859490      PMCID: PMC5508981          DOI: 10.1002/jnr.23984

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  30 in total

1.  Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype.

Authors:  P Bauer; F Laccone; A Rolfs; U Wüllner; S Bösch; H Peters; S Liebscher; M Scheible; J T Epplen; B H F Weber; E Holinski-Feder; H Weirich-Schwaiger; D J Morris-Rosendahl; J Andrich; O Riess
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

2.  Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.

Authors:  Natalia B Nedelsky; Maria Pennuto; Rebecca B Smith; Isabella Palazzolo; Jennifer Moore; Zhiping Nie; Geoffrey Neale; J Paul Taylor
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

3.  A rotarod test for evaluation of motor skill learning.

Authors:  Hiromi Shiotsuki; Kenji Yoshimi; Yasushi Shimo; Manabu Funayama; Yukio Takamatsu; Kazutaka Ikeda; Ryosuke Takahashi; Shigeru Kitazawa; Nobutaka Hattori
Journal:  J Neurosci Methods       Date:  2010-03-30       Impact factor: 2.390

4.  CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.

Authors:  H Fujigasaki; J J Martin; P P De Deyn; A Camuzat; D Deffond; G Stevanin; B Dermaut; C Van Broeckhoven; A Dürr; A Brice
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

Review 5.  TATA-binding protein in neurodegenerative disease.

Authors:  W M C van Roon-Mom; S J Reid; R L M Faull; R G Snell
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

6.  Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration.

Authors:  Meyer J Friedman; Anjali G Shah; Zhi-Hui Fang; Elizabeth G Ward; Stephen T Warren; Shihua Li; Xiao-Jiang Li
Journal:  Nat Neurosci       Date:  2007-11-11       Impact factor: 24.884

7.  Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.

Authors:  Shanshan Huang; Su Yang; Jifeng Guo; Sen Yan; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

8.  Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.

Authors:  Su Yang; Shanshan Huang; Marta A Gaertig; Xiao-Jiang Li; Shihua Li
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

9.  A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.

Authors:  Alexandra Kelp; Arnulf H Koeppen; Elisabeth Petrasch-Parwez; Carsten Calaminus; Claudia Bauer; Esteban Portal; Libo Yu-Taeger; Bernd Pichler; Peter Bauer; Olaf Riess; Huu Phuc Nguyen
Journal:  J Neurosci       Date:  2013-05-22       Impact factor: 6.167

10.  "Cryptic" repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes.

Authors:  B Gostout; Q Liu; S S Sommer
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  5 in total

1.  Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Authors:  Yang Yang; Su Yang; Jifeng Guo; Yiting Cui; Beisha Tang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-08-18       Impact factor: 6.167

2.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

3.  MANF regulates hypothalamic control of food intake and body weight.

Authors:  Su Yang; Huiming Yang; Renbao Chang; Peng Yin; Yang Yang; Weili Yang; Shanshan Huang; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Nat Commun       Date:  2017-09-18       Impact factor: 14.919

Review 4.  What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Authors:  Jasmine Donaldson; Sophie Powell; Nadia Rickards; Peter Holmans; Lesley Jones
Journal:  J Huntingtons Dis       Date:  2021

5.  Piperine ameliorates SCA17 neuropathology by reducing ER stress.

Authors:  Jifeng Guo; Yiting Cui; Qiong Liu; Yang Yang; Yujing Li; Ling Weng; Beisha Tang; Peng Jin; Xiao-Jiang Li; Su Yang; Shihua Li
Journal:  Mol Neurodegener       Date:  2018-01-30       Impact factor: 14.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.